Abstract:Neuromuscular and vascular hamartoma (NMVH) is a rare lesion arising chiefly in the small intestine. As it shares many of the histological features with other commonly occurring stricturous conditions of the small bowel, there is an ongoing debate whether it is truly hamartomatous or represents just a reactive condition. We are reporting a case of NMVH in the terminal ileum in a 32-year-old male who presented with symptoms of intestinal obstruction.
“…17 In total, there are fewer than 25 sporadic cases of NMVH and neuromesenchymal hamartoma reported in the world literature involving predominantly the small intestine in adult patients, although large bowel involvement, occurrence within a Meckel’s diverticulum, and childhood presentation are also described in isolated case reports. 7,8,11,12,18-32 Our case has many unique features in contrast to these reports.…”
Neuromuscular and vascular hamartoma (NMVH), also known as neuromesenchymal hamartoma, is a rare hamartomatous condition of the intestine. It usually presents with submucosal humps protruding in the intestinal lumen causing obstructive features. The other clinical manifestations are hematochezia or melena and protein-losing enteropathy. The etiopathogenesis of these lesions is not well known, although an association with small bowel Cröhn's disease and diaphragm disease had been postulated, the latter related to chronic nonsteroidal anti-inflammatory drug intake. Only 24 cases of NMVH are reported in the English literature and all of them could be adequately cured by resection of the affected part of the bowel. Moreover, none of these cases presented with abdominal cocoon or showed any evidence of vasculitis. We describe a peculiar case of NMVH in a 45-year-old male who presented with abdominal cocoon with symptomatic recurrence and fatal outcome within a month of surgery. Histopathology revealed classical histomorphology of NMVH with evidence of vasculitis. This appears to be the first case of a fatal form of NMVH, presenting with abdominal cocoon and associated with vasculitis.
“…17 In total, there are fewer than 25 sporadic cases of NMVH and neuromesenchymal hamartoma reported in the world literature involving predominantly the small intestine in adult patients, although large bowel involvement, occurrence within a Meckel’s diverticulum, and childhood presentation are also described in isolated case reports. 7,8,11,12,18-32 Our case has many unique features in contrast to these reports.…”
Neuromuscular and vascular hamartoma (NMVH), also known as neuromesenchymal hamartoma, is a rare hamartomatous condition of the intestine. It usually presents with submucosal humps protruding in the intestinal lumen causing obstructive features. The other clinical manifestations are hematochezia or melena and protein-losing enteropathy. The etiopathogenesis of these lesions is not well known, although an association with small bowel Cröhn's disease and diaphragm disease had been postulated, the latter related to chronic nonsteroidal anti-inflammatory drug intake. Only 24 cases of NMVH are reported in the English literature and all of them could be adequately cured by resection of the affected part of the bowel. Moreover, none of these cases presented with abdominal cocoon or showed any evidence of vasculitis. We describe a peculiar case of NMVH in a 45-year-old male who presented with abdominal cocoon with symptomatic recurrence and fatal outcome within a month of surgery. Histopathology revealed classical histomorphology of NMVH with evidence of vasculitis. This appears to be the first case of a fatal form of NMVH, presenting with abdominal cocoon and associated with vasculitis.
“…These lesions demonstrate haphazard, aberrant fascicles of smooth muscle from the muscularis mucosae, bundles of non-myelinated nerve fibres with scattered abnormal ganglion cells, and hemangiomatous vascular channels [1] , [2] . Debate exists regarding the hamartomatous nature of this disorder, given that many of the features of NMVH are seen in a range of reactive conditions, including Crohn’s disease, ischaemic enteritis, radiation enteritis and NSAID-induced small bowel strictures (so-called ‘diaphragm disease’) [2] , [6] , [7] .…”
HighlightsNeuromuscular and vascular hamartoma is a rare hamartomatous lesion of the intestine.Presents clinically as non-specific abdominal pain, intermittent obstructive symptoms, or occult gastrointestinal bleeding.Manifests as intestinal strictures or polypoid-like mass lesions.Shares clinical and histological features with several reactive conditions, such as Crohn’s disease.NMVH should be diagnosed with caution if the patient has known Crohn’s disease or a history of significant NSAID use.
“…Macroscopically, most of the cases show single or multiple strictures in the jejunum and ileum, including one case in the cecum . Characteristic histological findings include a haphazard distribution of fascicles of smooth muscle, vascular channels with thickened wall, thickened unmyelinated nerve bundles and S100‐positive, irregularly scattered ganglion cells . These findings are similar to those found in our patient.…”
Section: Discussionmentioning
confidence: 99%
“…Neuromuscular and vascular hamartoma (NMVH) of the small bowel is a very rare entity that causes intestinal strictures, resulted in recurrent small bowel obstruction or chronic gastrointestinal (GI) bleeding . It was first described by Fernando and McGovern in 1982 as a hamartomatous lesion, consisting of fascicles of smooth muscle derived from muscularis mucosa, bundles of unmyelinated nerve fibers with scattered ganglion cells and hemangiomatous vessels, that occurs focally within a segment of the small intestine.…”
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.